AU1360901A - Compositions and methods for controlled-release delivery and increased potency of pharmaceuticals via hydrophobic ion-pairing - Google Patents

Compositions and methods for controlled-release delivery and increased potency of pharmaceuticals via hydrophobic ion-pairing

Info

Publication number
AU1360901A
AU1360901A AU13609/01A AU1360901A AU1360901A AU 1360901 A AU1360901 A AU 1360901A AU 13609/01 A AU13609/01 A AU 13609/01A AU 1360901 A AU1360901 A AU 1360901A AU 1360901 A AU1360901 A AU 1360901A
Authority
AU
Australia
Prior art keywords
pairing
compositions
controlled
methods
release delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13609/01A
Inventor
Danielle Biggs
William Dernell
Lixin Feng
Derrick Katayama
Corinne S. Lengsfeld
Mark C Manning
Jeffrey D. Meyer
Douglas Pitera
Theodore W. Randolph
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Technology Corp
Original Assignee
University of Technology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Technology Corp filed Critical University of Technology Corp
Publication of AU1360901A publication Critical patent/AU1360901A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/541—Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU13609/01A 1999-11-01 2000-11-01 Compositions and methods for controlled-release delivery and increased potency of pharmaceuticals via hydrophobic ion-pairing Abandoned AU1360901A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US16282299P 1999-11-01 1999-11-01
US60162822 1999-11-01
US23125700P 2000-09-08 2000-09-08
US23137400P 2000-09-08 2000-09-08
US60231374 2000-09-08
US60231257 2000-09-08
PCT/US2000/030424 WO2001032218A1 (en) 1999-11-01 2000-11-01 Compositions and methods for controlled-release delivery and increased potency of pharmaceuticals via hydrophobic ion-pairing

Publications (1)

Publication Number Publication Date
AU1360901A true AU1360901A (en) 2001-05-14

Family

ID=27388802

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13609/01A Abandoned AU1360901A (en) 1999-11-01 2000-11-01 Compositions and methods for controlled-release delivery and increased potency of pharmaceuticals via hydrophobic ion-pairing

Country Status (4)

Country Link
EP (1) EP1225916A1 (en)
AU (1) AU1360901A (en)
CA (1) CA2389304A1 (en)
WO (1) WO2001032218A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7527807B2 (en) 2000-06-21 2009-05-05 Cubist Pharmaceuticals, Inc. Compositions and methods for increasing the oral absorption of antimicrobials
JP4566604B2 (en) * 2004-03-31 2010-10-20 塩野義製薬株式会社 Glycolabeling reagent
PL1750683T3 (en) 2004-04-23 2013-05-31 Amgen Inc Sustained release formulations
US20060134204A1 (en) * 2004-12-21 2006-06-22 Wong Patrick S Complexes made using low solubility drugs
AU2006242535B2 (en) 2005-04-29 2012-08-09 Merck Sharp & Dohme Corp. Therapeutic compositions
US20070042041A1 (en) * 2005-08-17 2007-02-22 Board Of Trustees Of The University Of Arkansas Drug-surfactant complexes for sustained release
ES2379829T3 (en) * 2006-09-14 2012-05-04 Bridge Bioresearch Rights (Jersey) Limited Healing of wounds and ulcers mediated by isoniazid
CN103772215B (en) * 2014-02-19 2015-11-25 赤峰艾克制药科技股份有限公司 The preparation method of L-synephrine
CA2953371C (en) * 2014-06-30 2021-08-24 Tarveda Therapeutics, Inc. Targeted conjugates and particles and formulations thereof
CN104771362B (en) * 2014-09-03 2018-01-02 沈阳药科大学 A kind of CLA ion pair lipide microsphere injection and preparation method thereof
DE102014013751A1 (en) * 2014-09-22 2016-03-24 Justus-Liebig-Universität Giessen Pulmonary drug formulation with delayed release
AU2016204933B2 (en) * 2015-07-14 2020-02-27 Best Pet Rx Ip, Inc. Poloxamer-based intralesional injections for the delivery of chemotherapeutic agents
CA3001712A1 (en) 2015-10-28 2017-05-04 Tarveda Therapeutics, Inc. Sstr-targeted conjugates and particles and formulations thereof
CN111551749A (en) * 2020-06-12 2020-08-18 郑州大学 Method for identifying drug target protein

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5171293A (en) * 1992-10-14 1994-05-09 Regents Of The University Of Colorado, The Ion-pairing of drugs for improved efficacy and delivery

Also Published As

Publication number Publication date
EP1225916A1 (en) 2002-07-31
CA2389304A1 (en) 2001-05-10
WO2001032218A1 (en) 2001-05-10

Similar Documents

Publication Publication Date Title
AU2879100A (en) Formulation and system for intra-oral delivery of pharmaceutical agents
AU4300701A (en) Methods and compositions for administration of therapeutic reagents
AU9224498A (en) Matrix for controlled delivery of highly soluble drugs
AU5945396A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
AU7547196A (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
AU6995396A (en) Pharmaceutical formulation
AUPN605795A0 (en) Analgesic pharmaceutical composition
AU7499096A (en) Stable freeze-dried pharmaceutical formulation
AU1267400A (en) Pharmaceutical moxifloxacin preparation
AU1360901A (en) Compositions and methods for controlled-release delivery and increased potency of pharmaceuticals via hydrophobic ion-pairing
AU6973396A (en) Pharmaceutical formulation
AU1061699A (en) Use of biologically active glass as a drug delivery system
AU5326100A (en) Pharmaceutical compositions and methods for use
AU1307399A (en) Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same
AU3556400A (en) Pharmaceutical compositions
AU4328800A (en) Pharmaceutical formulation
AU2543399A (en) Anticonvulsant drugs and pharmaceutical compositions thereof
AU6715600A (en) Pharmaceutical formulations
AU2773597A (en) Pharmaceutical compositions for the sustained release of insoluble active principles
AU6460400A (en) Pharmaceutical compositions
AU6605100A (en) Method and pharmaceutical composition for parenteral administration of iron
AU7582696A (en) Pharmaceutical formulation
AU4977300A (en) Pharmaceutical formulations
AU3953197A (en) Catechol amino acid derivatives and pharmaceutical compositions containing them
AU1930097A (en) Slow-release pharmaceutical formulations containing mizolastin

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase